KANSAS BIOSCIENCE AUTHORITY

Kansas has the largest concentration of animal health companies in the world. Their researchers are making breakthroughs in oncology, IT, medical devices, and other important areas of human health. And they're advancing solutions in agribusiness on the strength of their agricultural heritage.
KANSAS BIOSCIENCE AUTHORITY
Industry:
Biotechnology Impact Investing Venture Capital
Founded:
2004-01-01
Status:
Closed
Contact:
(913) 397-8300
Email Addresses:
[email protected]
Technology used in webpage:
SPF Google Maps GStatic Google Static Content Google Maps API Network Solutions DNS Intermedia SMTP.com
Similar Organizations
BioAdvance
BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.
Current Employees Featured
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2016-03-08 | Advanced Animal Diagnostics | Kansas Bioscience Authority investment in Series D - Advanced Animal Diagnostics | 1.7 M USD |
2015-05-18 | Flow Forward Medical | Kansas Bioscience Authority investment in Series A - Flow Forward Medical | 1.3 M USD |
2015-04-27 | Innara Health | Kansas Bioscience Authority investment in Series B - Innara Health | 3.7 M USD |
2015-02-23 | Artio Medical | Kansas Bioscience Authority investment in Series A - Artio Medical | 2 M USD |
2014-12-08 | Advanced Animal Diagnostics | Kansas Bioscience Authority investment in Series C - Advanced Animal Diagnostics | 15 M USD |
2014-03-12 | Health Outcomes Sciences | Kansas Bioscience Authority investment in Series A - Health Outcomes Sciences | 12.75 M USD |
2014-01-03 | Flow Forward Medical | Kansas Bioscience Authority investment in Series A - Flow Forward Medical | 4.4 M USD |
2013-01-31 | Aratana Therapeutics | Kansas Bioscience Authority investment in Series C - Aratana Therapeutics | 12 M USD |
2011-01-07 | Aratana Therapeutics | Kansas Bioscience Authority investment in Series A - Aratana Therapeutics | 20 M USD |
2010-12-31 | IGXBio | Kansas Bioscience Authority investment in Seed Round - IGXBio | 470 K USD |
Newest Events participated
